Article

Edmund Pezalla, MD, MPH, Analyzes the Future of Medicare Advantage Plans

Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, suggest that the healthcare industry will continue to move in the direction of providing patients incentives to make use of health risk assessment tools and screenings.

Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, suggest that the healthcare industry will continue to move in the direction of providing patients incentives to make use of health risk assessment tools and screenings. He says many of his organization’s programs have already been actively reducing or eliminating copays for preventive services as well as for certain sorts of critical medications.

“Benefit designs need to support delivery system reform by encouraging the right sorts of behaviors by both the consumers as well as the providers,” Dr Pezalla stated.

Related Videos
dr mohamad mohty
Kathryn Lindley, MD, FACC
dr jennifer vidrine
dr ryan jacobs
dr brian koffman
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Cente
John Hood, PhD
mily Touloukian, DO, medical oncologist, practice president, and managing partner at Coastal Cancer Center
drs almeida, landgren, and lee
Related Content
CH LogoCenter for Biosimilars Logo